echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > 【Nature Sub-Journal】Natural mechanism leads to a 50-fold increase in T cell activation sensitivity!

    【Nature Sub-Journal】Natural mechanism leads to a 50-fold increase in T cell activation sensitivity!

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    This article is original from Translational Medicine Network, please indicate the source for reprinting 

    Author: Jeff

    Introduction: Interactions between T-cell receptors (TCRs) and peptide major histocompatibility complex (pMHC) ligands are usually mediated by non-covalent bonds


    Researchers have identified a new mechanism by which T cells can respond to lower doses of antigen


    #Sec9

    'Accelerating' T cells

     01 

    While immunotherapy is a big step forward in treating some cancers and autoimmune diseases, this type of treatment doesn't work for many patients


    The team observed a previously unobserved immune interaction that had been invisible because T cell activation levels were above the threshold that normally causes these T cells to be 'deleted' from the immune system


    TCR-pMHC interaction

     02

    The interactions between TCR and pMHC ligands are very diverse, but the physiological TCR-pMHC interactions involving covalent bonds are unknown


    Since the kinetic schooling model assumes that T-cell activation requires the TCR-pMHC complex to persist long enough to activate TCR signaling, this model is sufficient to explain why long-lived, covalently bound TCR-pMHC complexes trigger T-cell activation


    T cell activation

     03 

    Here, by introducing Cys substitutions into a previously described mouse TCR, we show that Cys residues at the top of CDR3α or CDR3β are sufficient to redirect T cell fate in vivo


    Furthermore, by introducing amino acid substitutions in peptide epitopes, the researchers demonstrated SS bond formation between the TCR and various pMHC ligands


    References:


    https://medicalxpress.


    Note: This article is intended to introduce the progress of medical research and cannot be used as a reference for treatment plans


    Recommended · Live/Event

    August 31st 14:00-17:30 Guangzhou

    The 2nd Clinical Application Salon of New Diagnostic Technology

    Scan the code to participate for free

    September 15-16 09:00-17:30 Chongqing

    The First Southwest Single Cell Omics Technology Application Forum

    Scan the code to participate for free

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.